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Patients with neurofibromatosis type 2 (NF2) report that
their greatest problem is deafness.1 If a patient is due to be
rendered bilaterally deaf as is eventually the case in NF2
then the choice of hearing rehabilitation lies between a
cochlear implant and an auditory brainstem implant (ABI).
It is a usual practice to use an ABI in the NF2 population
as preserving the cochlear nerve during NF2-related
vestibular schwannoma (VS) removal is difficult, and
anatomical preservation does not guarantee functional
preservation.2
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Abstract Objectives A decision on whether to insert a cochlear implant can be made in
neurofibromatosis 2 (NF2) if there is objective evidence of cochlear nerve (CN) function
post vestibular schwannoma (VS) excision. We aimed to develop intraoperative CN
monitoring to help in this decision.
Design We describe the intraoperative monitoring of a patient with NF2 and our
stimulating and recording set up. A novel test electrode is used to stimulate the CN
electrically.
Setting This study was set at a tertiary referral center for skull base pathology.
Main outcome measure Preserved auditory brainstem responses leading to cochlear
implantation.
Results Electrical auditory brainstem response (EABR) waveforms will be displayed
from different stages of the operation. A cochlear implant was inserted at the same
sitting based on the EABR.
Conclusion Electrically evoked CN monitoring can provide objective evidence of CN
function after VS excision and aid in the decision-making process of hearing rehabilita-
tion in patients who will be rendered deaf.
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Several centers around the world have inserted a cochlear
implant following objective cochlear nerve testing at the time
of VS surgery for hearing rehabilitation.3–6 This is especially
relevant when the approach to the tumor is the translabyr-
inthine route which will destroy any residual hearing. In
patients who will eventually lose their hearing bilaterally
such as in NF2, it is essential that the best means of hearing
rehabilitation is provided. Compared with the conventional
ABI used in such cases, the cochlear implant provides better
hearing.7 Insertinga cochlear implant at thesamesittingas the
VS removal will reduce the number of operations and proce-
dures that such patients will need to undertake. Implantation
as soon as is possible is also preferred as it reduces the chances
of cochlear ossification preventing cochlear implantation.5,8
Methods of Monitoring the Cochlear Nerve
Surgeons and neurophysiologists have tried various systems
to monitor the cochlear nerve to predict its function post-
operatively.4,9–12 These are based on the principle that the
nerve is stimulated at or near the cochlea and this stimulus is
detected either by measuring the electrical activity that is
induced directly from the cochlear nerve (cochlear nerve
action potential [CNAP]) or further along the auditory path-
way (the auditory brainstem response [ABR]) (see ►Fig. 1).
The stimulus can be in the form of auditory “clicks” intro-
duced into the ear canal via earphones (ABR) or via electrical
stimulation of the cochlea and the cochlear nerve resulting in
an electrical auditory brainstem response (EABR). The most
investigated methods of intraoperative cochlear nerve mon-
itoringhavebeenABRandauditoryclick-stimulatedCNAP.13,14
They are also the methods of choice that are being utilized in
most skull base centers that operate on VS.
Any intraoperative monitoring that utilizes ABR techni-
ques is at a disadvantage as it does not allow real-time
feedback of cochlear nerve function.15 CNAP is preferable
as it eliminates the need for recording many hundreds of
repetitions to obtain a reliable waveform, as the CNAP
amplitude is much larger than that of an ABR. There is also
less background electrical noise when recording from the
nerve directly than from scalp electrodes.15
Changes in the Monitoring Waveforms:
What Is Significant?
Decidingwhen theABRor CNAP is indicative of cochlear nerve
damage is not straightforward.During theABR, the decrease in
amplitude or the increase in latency of the waves are the two
means of determining when there might be damage to the
nerve.16 The main waves looked at during an ABR are waves I,
III, and V,withwave V being themost robust.Wave I, III, and V
latencies, aswell as interwave latencies of waves I–III, I–V, and
III–V, are also commonly analyzed.17 Monitoring with CNAP
usually requires an evaluation of amplitude change and action
potential morphology. The process can be quite subjective
when trying to determine if a waveform exists within a back-
ground of the electrical artifact.
Many clinicians support an arbitrary ABRwarning criterion
of a 50% decrease in amplitude and/or a 1 ms increase in
latency for wave V.18,19 This is not an unreasonable criterion,
but it has not been demonstrated to be predictive of post-
operative function for monitoring of the auditory system.20 It
is also likely that the optimal warning criteria depend on the
type of surgical procedure. For CPA surgeries other than tumor
resection, such as neurovascular decompression, hearing loss
occurs only when there is a permanent loss of wave V.21,22
Monitoring during Translabyrinthine
Surgery
Acoustic stimuli, however, cannot be undertaken following
translabyrinthine surgery to gain access to the VS as residual
hearing is lost during the drilling of the vestibular apparatus
with loss of inner ear fluid. Anymonitoring employed during
a translabyrinthine surgical approachmust, therefore, utilize
electrical stimulation of the cochlear nerve. This can be via
Fig. 1 Simplified schematic diagram of the auditory pathway. The boxed text indicates possible sites for stimulation and recording along the
auditory pathway during vestibular schwannoma surgery.
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stimulating at the middle ear promontory or round window
niche with ABR (far-field) or CNAP (near-field) recording.
Lloyd et al6 recently reported their use of electrically stimu-
lated CNAP to gage the integrity of the cochlear nerve before
cochlear implantation for hearing rehabilitation following
translabyrinthine resection of VS.
This article describes one of our first attempts at intrao-
perative EABR in an NF2 patient to insert a cochlear implant
to aid in hearing rehabilitation. We utilized the techniques
we had learned over the last 5 years to monitor the cochlear
nerve so we could achieve our aim of optimum hearing
rehabilitation.
Methods
A 37-year-old female patient affected by NF2, in Decem-
ber 2013 had undergone a left-sided translabyrinthine exci-
sion of VS along with insertion of a sleeper ABI. This
procedure had removed all hearing on his left side, but the
patient had serviceable hearing on the right side. During
2014, the right-sided hearing levels deteriorated signifi-
cantly to the American Academy of Otolaryngology and
Head Neck Surgery (AAOHNS) Class D23 due to a slowly
increasing 2 cm VS. The tumor was mainly within the CPA
with some extension into the fundus of the internal auditory
meatus (IAM). The decision to remove the tumor with an
attempt to preserve the cochlear nerve was taken function-
ally. This would allow a cochlear implant to be inserted with
better hearing rehabilitation.
The following monitoring techniques were developed as
part of a research study registered with the Cambridgeshire
Research Ethics Committee (reference 08/H0308/76). The
Medelec Synergy system (VIASYS HealthCare UK, Surrey, Uni-
tedKingdom)wasused tomonitor the cochlear nerve via EABR
(using far-field electrodes). Our previous work (unpublished)
showedan intracochlear electrode to be superior in electrically
stimulating the auditory pathway. Wewere also unable to use
our custom-made electrodedue to problemswithmanufactur-
ing the device. In response to our request, a cochlear implant
manufacturing companyMED-EL (Innsbruck,Austria)wasable
to provide us with a “test” intracochlear electrode. The test
electrode was used as a custom-made device on a named
patient basis. This was similar to a cochlear implant electrode
array but with four intracochlear electrodes spaced 4.2 mm
apart (total array length: 18mm), and an extracochlear return
electrode if needed which is embedded into the temporalis
muscle (see ►Fig. 2). The diameter at the array tip is 0.5 mm.
For monitoring to take place using an intracochlear elec-
trode, access to the middle ear is required, and the electrode
is inserted through the round window, similar to cochlear
implant surgery. For this case, the entire array was inserted
into the cochlea and was stimulated at electrode 2 with the
return chosen as electrode 4. The electrode is kept in place
with some bonewax securing it near the roundwindow. The
time taken for this added surgical step is in our experience
not more than a couple of minutes. However, obtaining a
baseline waveform fromwhich to begin monitoring can take
a fewmoreminutes as stimulation and recording parameters
need to be adjusted according to the patient and surgical
factors. For example, a higher current stimulus is needed if
high electrode impedance is encountered. It is important to
note that this technique will likely destroy any residual
hearing and therefore is usually employed in cases of the
translabyrinthine approach when the hearing is sacrificed.
This technique is not suitable for stimulation via broadband
“clicks” to monitor residual hearing in which only recording
electrodes are needed.
The MED-EL electrode is stimulated by an ABI stimulator
box, which generates biphasic stimulation pulses and is
controlled by the MED-EL diagnostic interface box via the
coil placed on the ABI stimulator box. The stimulation pulses
are synchronizedwith the recording system using a standard
“TTL” signal.►Table 1 details the specific stimulationmethod
and the parameters used. Testing was undertaken at various
stages during surgery and at the end of tumor removal.
Initial wave III and V amplitude and latency were mea-
sured as a baseline at the prelabyrinthectomy stage. Criteria
to warn the surgeon as to impending cochlear nerve damage
was a wave V latency prolongation of over 1 ms and ampli-
tude reduction greater than 50%.
Results and Analysis
Initial testing prelabyrinthectomy determined that 1,000
cochlear units were an adequate stimulation to produce an
EABR. A selection of recordings will be displayed at various
stages along the surgery along with latency values where
appropriate.
Fig. 2 Stimulating intracochlear electrode array manufactured by MED-EL (Innsbruck, Austria).
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The top two traces in ►Fig. 3 showed a lengthening of
EABR before wave III indicating pathology proximal to the
cochlear nucleus. Postlabyrinthectomy the EABR was intact
aswould be expected. During and after IAMdrilling the EABR
was still clearly recognizable, without loss of wave III and V
amplitude or latency. During tumor and nerve dissection, the
EABR was preserved for a while till further tumor and nerve
dissection (►Fig. 4, traces 25–27) caused loss of a clear wave
III and widening of wave V morphology with an increase of
wave V latency to 5.3 ms. Traces 28 to 30 were undertaken as
the tumor capsule was being dissected from the cochlear
nerve causing a >50% decrease in wave V amplitude and an
increase in latency of 0.6 to 0.9 ms.
At this stage in operation, the surgeon was warned of the
possible damage to the cochlear nerve when a>50% decrease
inwave Vamplitudewas detected. At the same time, the facial
nerve was depolarized and detected by the facial nerve
monitoring system. The surgeon stopped tumor dissection
andallowed thenerve to recover fora fewminutes. Recoveryof
baseline EABR did not occur, and therefore the surgeon con-
tinuedgentledissection changinghisdissection techniqueand
approach. During further tumor and nerve dissection (►Fig. 5,
recordings 49–51), the EABR showed a possible wave V with
grossly widened morphology and>50% amplitude reduction.
Recordings 52 to 54 show a complete loss of wave V with
further tumor dissection from the cochlear nerve.
Table 1 Displaying the stimulation and recording parameters
for cochlear implant EABR
Parameter
Stimulus presentation Med-el intracochlear electrode 2
Return electrode Intracochlear electrode 4
Type of stimulus Electrical
Rate of stimulation 31/s
Level of stimulation Variable
Pulses Biphasic, variable phase
width 50–200 μs
Recording Montage
(surface electrodes)
Positive: high forehead (Fz)
Negative: C7
Ground: contralateral shoulder
Filter
High pass 30 Hz
Low pass 3,000 Hz
Amplifier gain 50,000
Sweep time 10 ms
Number of sweeps 2,048
Abbreviation: C7, electrode placement over the seventh cervical
vertebrae.
Fig. 3 Prelabyrinthectomy EABR. The bottom two traces utilized a bipolar stimulation method with stimulation at electrode 2 and return
electrode 3. This stimulation technique produced a poorer waveform and was therefore not utilized further. Waves are marked where seen. Wave
I wheremarkedmay be stimulation artifact. Individual traces are labeled with the stimulating and return electrode number (E), cochlear unit (CU)
level, μs phase width, and time of recording. Each division/dot in the x-axis is 1 ms, and 0.5 μV in the y-axis. EABR, electrical auditory brainstem
response.
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Fig. 4 Further tumor and nerve dissection EABR (traces 25 to 27). Loss of a clear wave III and widening of wave V morphology was seen with an
increase in wave V latency to 5.3 ms. Traces 28 to 30 were undertaken as the tumor capsule was being dissected from the cochlear nerve causing
a >50% decrease in wave V amplitude and an increase in latency of 0.6 to 0.9 ms. Wave I where marked may be stimulation artifact. EABR,
electrical auditory brainstem response.
Fig. 5 During further tumor and nerve dissection EABR. Recordings 49 to 51 showed a possible wave V with grossly widened morphology and
>50% amplitude reduction. Recordings 52 to 54 show a complete loss of wave V with further tumor dissection from the cochlear nerve. Waves
are marked where seen. Wave I where marked may be stimulation artifact.
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At the completion of tumor resection EABR there was a
complete lossofEABR(►Fig. 6, recordings55–56).At thispoint,
the cochlear nerve was bathed in the antispasmodic agent
papaverine. This improved the EABR and showed features of
wave V with a characteristic downward slope. This is easier to
appreciatewhen comparedwith recordings 49 to 51 in►Fig. 5.
At this stage, a Nucleus Freedom cochlear implant was
inserted into the same side as tumor removal had taken
place. Further cochlear implant EABR testing did not produce
convincing EABR traces. Increasing the stimulation level
eventually caused the facial nerve to depolarize at which
point testing was stopped.
Discussion
Our aim at the start of the operation was to preserve the
cochlear nerve leading to cochlear implantation functionally.
This shouldhowevernotoverride theprimaryobjective,which
was total/near-total tumor removal with preservation of the
facial nerve. Initially,monitoringmust take placewith far-field
techniques using EABR, but once access is gained to the
proximal part of the cochlear nerve, a direct cochlear nerve
recording electrode, such as the Cueva electrode (AD-TECH
Medical Instrument Corporation) can be attached allowing
CNAP to take place.10 Unfortunately, CNAP monitoring, in this
case, was not possible as it was problematic to place the Cueva
electrode in a suitable position to record reliable waveforms.
The potential problems with recording CNAP with electrical
stimulation, rather than the usual auditory stimulation are
numerous and include electrical artifact and current shunting
due to cerebrospinal fluid flow.11 Our monitoring, therefore,
consisted of EABR throughout.
Changes in EABR waveform vary between near-field
(direct cochlear nerve recording, e.g., CNAP) and the far-field
(using scalp electrodes) technique. The former will allow
near-real-timemonitoring. Far-field techniques rely on aver-
aging several hundred responses to obtain a reliable wave-
form as was utilized in our case. This method introduces a
delay between a damaging surgical maneuver and an abnor-
mal waveform of between 15 seconds and 1 minute. The
electrophysiologist must then interpret the waveform
changes from the baseline waveform and warn the surgeon.
In practice, this takes a few seconds. Software packages that
can detect changes in EABR waveform are not in widespread
use due to the complexity of the EABR and the pattern
changes that can result due to cochlear nerve damage. We
used a highly experienced electrophysiologist to interpret
the EABR waveform changes during the operation visually.
Effects on the EABR during Surgery
During intraoperative monitoring of the cochlear nerve, there
are obvious surgicalmaneuvers thatmay change the auditory-
evoked potentials. Systemic factors, such as hypotension or
hypothermia, during surgery, can affect the waveform ampli-
tude and latency. Irrigation of the surgical field will cause a
local hypothermic effect and can increase the latency of wave I
and interwave latencies.24 This effect is greater when tem-
peratures are less than 26°C and can double latency times
normally measured at 37°C. Waveform amplitude has a more
complex relationship with temperature and can initially
increase before decreasing at temperatures below 30°C.25
Effects of anesthesia have less of an effect on auditory-evoked
potentials.26 The changes described are usually reversible and
therefore irrigation with warm saline or the infusion of
intravenous fluids to correct hypothermia and hypotension,
respectively, will correct any shift in wave latency and ampli-
tude. The recognition of these abnormalities when there is a
shift inwaveformlatencyoramplitude is important soasnot to
mistake them for cochlear nerve damage.
A Closer Analysis of the Intraoperative EABR
Initial EABR tracespretumordissection showwaveV latencyat
5.1ms and amplitude at between 0.85 and 1.05 V. This latency
value is delayed by almost three standard deviations and
approximately 1 ms when compared with the normative
EABR data.27 This increase in latency occurs between waves
I and III as the interwave latency wave III to V is normal. This
would correlate with a lesion located on the cochlear nerve,
which would affect nerve conduction between sites respon-
sible for the generation of waves I and III of the ABR. Drilling of
the IAM is commonly associatedwith sudden loss of auditory-
evokedpotentials.28This, fortunately, didnotoccur inour case.
The mechanism of injury is proposed to be a combination of
noise, physical damage, and vascular compromise.29
AnEABRwaswell preserved until tumor capsule dissection
from the cochlear nerve at which point only wave V could be
recognized. Traces 28 to 30 (►Fig. 4) were undertaken as the
tumor capsule was being dissected from the cochlear nerve
and shows a >50% decrease in wave V amplitude and an
increase in latency from 5.1 to 5.7 ms. This amplitude drop
of approximately 50% frombaselinewas thepoint atwhich the
surgeon was warned of possible cochlear nerve damage. The
EABR, however, did not return despite waiting for 5 minutes.
Before the sudden decrease in wave V amplitude, the mor-
phology of wave V was widened (see recordings 25–27
in►Fig. 4), and this may have been a more sensitive indicator
of impending cochlear nerve damage. Measuring the angle
between the ascending and descending limb of wave V may
provide a means to quantify this abnormal morphology.
Dissecting the tumor from the cochlear nerve is a delicate
process and damage to the nerve can occur from mechanical
trauma, thermal damage (from electrocautery), or ischemia
(vessel damage). Traction injury on the nerve can occur and is
most likely to cause harm to the distal end, with avulsion of
fragile nerve endings at the cochlea. This would cause a loss of
wave I andsubsequentwaves. It is consequently recommended
that should traction be required during dissection; it should be
applied toward the cochlea rather than away from it.30
NF2 tumors tend to be multilobular and often demon-
strate amore invasive growth pattern than solitary tumors.31
Thus, they are harder to separate from the cochlear nerve
during dissection, and consequently, there are higher rates of
cochlear nerve damage during surgery.
►Figs. 5 and 6 display recordings at near completion of
tumor dissection and the end of the procedure, respectively.
The possiblewave V demonstrated latencies, which decreased
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to approximately 4.6ms. This is a decrease from thebaseline of
5.1ms. This could have been due to the release of compression
of the cochlear nerve from the VS allowing a more normal
signal conduction. Another possibility is that cerebellar retrac-
tion was released. This would release pressure on the small
vessels supplying the cochlear nerve (and reverse any nerve
ischemia), or mechanical stretching of the cochlear nerve.32
The Use of Papaverine
The addition of the antispasmodic agent papaverine into the
surgicalfieldcauseda returnofwaveV,albeitof lowamplitude
and abnormalmorphology. The characteristic negative peak at
5 ms corresponded to the wave V negative peak earlier in the
recordings. Papaverine has been used by others in the past
with some success in the reversal of neurophysiological
changes in the cochlear nerve.26,33 Papaverine is a phospho-
diesterase inhibitor that relaxes the smooth muscle of the
vascular system and is routinely used in vascular surgery.34
The internal auditory artery (or labyrinthine artery) runs
within the IAM supplying the inner ear and cochlear nerve
and is susceptible to injury, either vasospasmor transection.26
The addition of papaverine caused a return of wave V and
suggested that the blood supply to the cochlear nerve was in
spasm and not irreversibly damaged at this time.
The administration of intraoperative steroids is routine in
our unit during VS surgery. Steroids have been shown to have
a beneficial effect on sudden sensorineural hearing loss.35
They are also shown to improve cochlear spiral ganglion cell
survival due to cochlear nerve compression in the rat
model.36 More recently, therapy with vasoactive treatments
perioperatively have shown mixed results in improving the
rates of hearing preservation surgery.37–39 Gouveris et al38
did not find any benefit in administering steroids and
vasoactive treatment to patients with the immediate post-
operative hearing loss after VS surgery. Unfortunately, no
intraoperative ABR traces were obtained, and therefore the
patients could not be classified into those that may benefit
from such treatment, and those that are unlikely to. Bischoff
et al39 found that only patients with reversible loss of wave V
benefited from vasoactive treatment. Furthermore, patients
benefited more so when the treatment was initiated pre-
operatively.40 Treatments in the studies were also almost
universally administered systemically, either intravenously
or orally. Our patient did not receive preoperative vasoactive
treatment, or the agent systemically. This may have reduced
the effect of the papaverine. It was nevertheless interesting
to see an abnormal wave V returns with its topical applica-
tion, lending credibility to its perioperative use in the future.
The Decision to Insert a Cochlear Implant
With the presence of awave V, albeit with abnormalmorphol-
ogy, latency, and amplitude according to theAmerican Society
of Neurophysiological Monitoring (ASNM) statement,16 the
decision to insert a cochlear implant was taken. This was a
complex decision-making process as the choice for the sur-
geonwas either to leave tumor behind to increase the chances
of a functioning cochlear nerve, or to remove all the tumor and
risk damaging the nerve. Complete tumor removal had taken
Fig. 6 Completion of tumor resection EABR. Recordings 55 and 56 showed a complete loss of EABR. Traces 57 and 58 are recordings after the
addition of the antispasmodic agent papaverine applied over the cochlear nerve. They display some features of a wave V. Waves are marked
where seen.
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place in this case, and with the slender hope of a functioning
nerve, a cochlear implant was inserted. Unfortunately, no
recognizable waveforms could be made out during cochlear
implant EABR (not shown). The patient’s cochlear implant did
not produce any auditory sensation at 3 months postsurgery.
At the time of surgery a hybrid ABI–cochlear implant was not
available to us, which would have been preferable to implant
given the abnormal ABR post excision.
There are however reports of successful outcomes with
cochlear implantation despite a lack of an EABR. These cases
are, however, in children with auditory neuropathy with a
variety of disorders affecting sound processing and not in
patients having had surgery affecting the cochlea and
cochlear nerve.
Finally, it is worth considering the possible cochlear
trauma of using a temporary intracochlear electrode for
monitoring purposes. The insertion of such an electrode
should be as careful as introducing a real implant electrode,
with adequate fixation at the round window to prevent
movement during surgery.
Conclusion
Intraoperative monitoring of the cochlear nerve is espe-
cially difficult with electrical stimulation during the trans-
labyrinthine approach. This case demonstrates the
problems in interpreting the EABR, and also the challenges
in deciding on whether to insert a cochlear implant. The use
of the stimulating MED-EL electrode greatly helps in this
technique and is invaluable in this setting. The return of an
abnormal EABR after its complete loss is not predictive of
cochlear nerve functional preservation and does not war-
rant cochlear implantation. Larger scale studies are required
in patients with and without NF2 to corroborate our
findings.
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